BUILD-3 study with bosentan in idiopathic pulmonary fibrosis does not meet … – PR-inside.com (press release)
posted on Mar 01 by pregnancy hypertension - Google News in the Uncategorized categoryBUILD-3 study with bosentan in idiopathic pulmonary fibrosis does not meet ... PR-inside.com (press release) Notes to the Editor About pulmonary arterial hypertension (PAH) Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized ... BUILD-3 study with bosentan in idiopathic pulmonary fibrosis does not meet ... |



